Profile
Helen established FoundersX Ventures in 2016 with the support of Stanford circle of founders.
Bringing over 10 years of product experience in high-tech industry, she leads a high-performing team investing in entrepreneurs defining the future and breaking barriers in biotech, Fintech, enterprise SaaS and low carbon solutions, with 5 unicorns, multiple home runs and more than 20 portfolio companies valued at over $100M.
Helen is featured on WSJ Pro Venture Capital and Business Insider as a Pioneering Biotech VC.
She is a member of 100 Women in Finance and Harvard PE/VC Class of 2022.
She is also a guest lecturer at Stanford University and an invited speaker at TechCrunch.
Helen is based in Silicon Valley.
Helen Liang active positions
| Companies | Position | Start |
|---|---|---|
Foundersx LLC
 Foundersx LLC Investment ManagersFinance Foundersx LLC (FoundersX) is a venture capital firm founded in 2016 by Helen H. Liang. The firm is headquartered in Menlo Park, California. | Founder | 2016-02-29 |
Cognito Therapeutics, Inc.
 Cognito Therapeutics, Inc. BiotechnologyHealth Technology Cognito Therapeutics, Inc. is a clinical-stage neurotechnology company based in Cambridge, MA. Cognito Therapeutics is developing disease-modifying therapeutic approaches to treat neurodegenerative disorders using its non-invasive neuromodulation platform. The company's lead therapy is currently in a pivotal study (HOPE) in Alzheimer's disease and has been awarded FDA breakthrough device designation. Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases. The company was founded by Li-Huei Tsai and Ed Boyden, and Brent A. Vaughan has been the CEO of the company since 2020. | Director/Board Member | 2022-05-31 |
Markable, Inc.
 Markable, Inc. Packaged SoftwareTechnology Services Markable, Inc. develops a visual search technology in fashion that connects photos and products. It allows users to spot a photo from a social network, phone gallery, and freshly snapped; mark the product; find the product or the best matches; and to purchase the product. The company was founded Joy Tang in 2013 and is headquartered in Madison, WI. | Director/Board Member | 2016-08-31 |
Former positions of Helen Liang
| Companies | Position | End |
|---|---|---|
| UstartX, Inc. | Chief Executive Officer | 2015-11-30 |
Training of Helen Liang
| University of Wisconsin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Foundersx LLC
Foundersx LLC Investment ManagersFinance Foundersx LLC (FoundersX) is a venture capital firm founded in 2016 by Helen H. Liang. The firm is headquartered in Menlo Park, California. | Finance |
Markable, Inc.
Markable, Inc. Packaged SoftwareTechnology Services Markable, Inc. develops a visual search technology in fashion that connects photos and products. It allows users to spot a photo from a social network, phone gallery, and freshly snapped; mark the product; find the product or the best matches; and to purchase the product. The company was founded Joy Tang in 2013 and is headquartered in Madison, WI. | Technology Services |
| UstartX, Inc. | |
Cognito Therapeutics, Inc.
Cognito Therapeutics, Inc. BiotechnologyHealth Technology Cognito Therapeutics, Inc. is a clinical-stage neurotechnology company based in Cambridge, MA. Cognito Therapeutics is developing disease-modifying therapeutic approaches to treat neurodegenerative disorders using its non-invasive neuromodulation platform. The company's lead therapy is currently in a pivotal study (HOPE) in Alzheimer's disease and has been awarded FDA breakthrough device designation. Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases. The company was founded by Li-Huei Tsai and Ed Boyden, and Brent A. Vaughan has been the CEO of the company since 2020. | Health Technology |
- Stock Market
- Insiders
- Helen Liang
